Erythropoietin Mediates Neurobehavioral Recovery and Neurovascular Remodeling Following Traumatic Brain Injury in Rats by Increasing Expression of Vascular Endothelial Growth Factor
- 29 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Stroke Research
- Vol. 2 (4), 619-632
- https://doi.org/10.1007/s12975-011-0120-2
Abstract
Erythropoietin (EPO) improves functional recovery after traumatic brain injury (TBI). Here, we investigated the role of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2) on EPO-induced therapeutic efficacy in rats after TBI. Young male Wistar rats were subjected to unilateral controlled cortical impact injury and then infused intracerebroventricularly with either a potent selective VEGFR2 inhibitor SU5416 or vehicle dimethyl sulfoxide. Animals from both groups received delayed EPO treatment (5,000 U/kg in saline) administered intraperitoneally daily at 1, 2, and 3 days post-injury. TBI rats treated with saline administered intraperitoneally daily at 1, 2, and 3 days post-injury served as EPO treatment controls. 5-Bromo-2′-deoxyuridine was administered to label dividing cells. Spatial learning and sensorimotor function were assessed using a modified Morris water maze test and modified neurological severity score, respectively. Animals were sacrificed at 4 days post-injury for measurement of VEGF and VEGFR2 or 35 days post-injury for evaluation of cell proliferation, angiogenesis, and neurogenesis. EPO treatment promoted sensorimotor and cognitive functional recovery after TBI. EPO treatment increased brain VEGF expression and phosphorylation of VEGFR2. EPO significantly increased cell proliferation, angiogenesis, and neurogenesis in the dentate gyrus after TBI. Compared to the vehicle, SU5416 infusion significantly inhibited phosphorylation of VEGFR2, cell proliferation, angiogenesis, and neurogenesis as well as abolished functional recovery in EPO-treated TBI rats. These findings indicate the VEGF⁄VEGFR2 activation plays an important role in EPO-mediated neurobehavioral recovery and neurovascular remodeling after TBI.Keywords
This publication has 74 references indexed in Scilit:
- Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injuryBrain Research, 2011
- The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: Functional outcome and gene expression profileBrain Research, 2011
- Thymosin β4 improves functional neurological outcome in a rat model of embolic strokeNeuroscience, 2010
- Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocritBrain Research, 2009
- Survival and proliferative roles of erythropoietin beyond the erythroid lineageExpert Reviews in Molecular Medicine, 2008
- Post‐ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemiaBritish Journal of Pharmacology, 2007
- Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic strokeBrain Research, 2007
- Behavioral tests for preclinical intervention assessmentNeuroRX, 2006
- Neurorestorative treatment of stroke: Cell and pharmacological approachesNeuroRX, 2006